Table 2.
Characterisation of five probabilistic models that use the Bayesian network approach and an AOP construct
| Model purpose | Adverse outcome | Mechanistic knowledge and associated data | Quantitative approach | Regulatory applicability | References | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OECD AOP-Wiki a | Type of AOPd | Type of chemical model applied to | Data type | Adjacent KERs | Biological level(s) | D/C–Re | T–Rf | |||||
| The risk posed by pesticides and environmental stressors to population size of Chinook salmon | Alteration of population dynamics | Nob | AOPN | Mixtures | In vitro experimental data, literature data, AOP construction, environmental factors, population characteristics | √ | Molecular, cellular, organ, organism, population | √ | √ | Bayesian Network-Relative Risk type of model | Ecological risk assessment | Chu (2018) |
| Effects on reproduction of Lemna minor (duckweed) | Reduced number of fronds | AOP ID 245 | LAOP | Single chemical | In vitro experimental data, AOP construction | √ | Molecular, cellular, organism | √ | – | Bayesian network type of model (discrete states as three intervals) | Ecological risk assessment | Moe et al. (2018) |
| Toxicity of silver nanoparticles, linking MIE to the AO | Reproduction failure | AOP ID 207 | LAOP | Nanoparticles | In vitro experimental data, literature data, AOP construction | √ | Molecular, cellular, organ, organism | √ | √ | Bayesian network type of model (discrete states as yes/no, and decrease/stable/increase), Boostrapping | Ecological risk assessment | Jeong et al. (2018) |
| Occurrence of steatosis under different chemical exposures | Hepatic steatosis | Noc | AOPN | Mixtures | Expert judgment, literature data, AOP construction | √ | Molecular, cellular, tissue, organ | √ | – | Bayesian network type of model (discrete states as active or inactive) | Human health risk assessment | Burgoon et al. (2020) and Perkins et al. (2019a) |
| Comparison between probabilistic and mechanistic approaches | Nephron attrition leading to chronic kidney disease | AOP ID 284 | LAOP | Single chemical | In vitro experimental data on human RPTEC/TERT1 cells, AOP construction | √ | Molecular, cellular, tissue, organ | √ | √ | Dynamic Bayesian network type of model | Human health risk assessment | Zgheib et al. (2019)g |
aNumbers represent the indices (XXX) of the AOP in the AOP-Wiki available at https://aopwiki.org/aops/XXX
bModel follows an AOP structure, the MIE (ID 12) can be found in the AOP-Wiki, however the AOP itself is not yet published
cModel is included in the AOPXplorer tool (https://apps.cytoscape.org/apps/aopxplorer) as it follows the structure of an AOP network
dLinear AOP (LAOP), AOP Network (AOPN)
eDose/Concentration–Response (D/C–R)
fTime–Response (T–R) describing the time-course behaviour
gModel represents a combination of both probabilistic and mechanistic approaches